Michael McGoon, MD
Mayo Clinic College of Medicine
Rochester, Minnesota

Presentation Title
Screening Populations at Risk for Pulmonary Arterial Hypertension and the Role of a Registry (Summary of Presentation)

Dr. Michael McGoon is Professor of Medicine and Consultant in Cardiology at the Mayo Clinic College of Medicine, in his hometown of Rochester, Minnesota, where he also serves as Associate Chair (Personnel) of the Division of Cardiovascular Diseases.  He has been Director of the Pulmonary Hypertension Clinic there since he initiated it in 1996. 

Dr. McGoon received his medical degree from the Johns Hopkins School of Medicine.  After his internship and one year of residency at Hopkins, he transferred to Mayo for his final year of residency and cardiology training. He has remained on staff at Mayo since then.  During his cardiology fellowship, he developed an interest in the hemodynamic and physiologic effects of vasodilators and other medications in patients with pulmonary hypertension under the mentorship of Dr. Ronald Vlietstra, Dr. Valentin Fuster and Dr. Paul Vanhoutte. That interest led to participation in multiple clinical trials of pulmonary vascular medications, starting with prostacyclin, and continuing to the present time. Dr. McGoon is board certified in Internal Medicine and in Cardiology.  He has been a member of the Scientific Advisory Board (now Scientific Leadership Council) of the Pulmonary Hypertension Association (PHA) since 1994, serving as its Chair from 2002 to 2004. He is currently Chair of the Board of Trustees of the PHA (2006-2008), and Chair of the Steering Committee of the Registry to Evaluate Early and Long-term Pulmonary Arterial Hypertension (PAH) Disease Management (REVEAL).